1. HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancers
- Author
-
Akhina Palollathil, Revathy Nandakumar, Mukhtar Ahmed, Anoop Kumar G. Velikkakath, Mahammad Nisar, Muhammad Nisar, Rex Devasahayam Arokia Balaya, Sakshi Sanjay Parate, Vidyarashmi Hanehalli, Althaf Mahin, Rohan Thomas Mathew, Rohan Shetty, Jalaluddin Akbar Kandel Codi, Amjesh Revikumar, Manavalan Vijayakumar, Thottethodi Subrahmanya Keshava Prasad, and Rajesh Raju
- Subjects
Drug resistance ,Head and neck cancer ,Chemotherapy ,Signaling pathway ,Transcriptional reprogramming ,Medicine ,Science - Abstract
Abstract Drug resistance poses a significant obstacle to the success of anti-cancer therapy in head and neck cancers (HNCs). We aim to develop a platform for visualizing and analyzing molecular expression alterations associated with HNC drug resistance. Through data mining, we convened differentially expressed molecules and context-specific signaling events involved in drug resistance. The driver genes, interaction networks and transcriptional regulations were explored using bioinformatics approaches. A total of 2364 differentially expressed molecules were identified in 78 distinct drug-resistant cells against 14 anti-cancer drugs, comprising 1131 mRNAs, 746 proteins, 62 lncRNAs, 257 miRNAs, 1 circRNA, and 166 post-translational modifications. Among these, 255 molecules were considerably, the signature driver genes of HNC drug resistance. Further, we also developed a landscape of signaling pathways and their cross-talk with diverse signaling modules involved in drug resistance. Additionally, a publicly-accessible database named “HNCDrugResDb” was designed with browse, query, and pathway explorer options to fetch and enrich molecular alterations and signaling pathways altered in drug resistance. HNCDrugResDb is also enabled with a Drug Resistance Analysis tool as an initial platform to infer the likelihood of resistance based on the expression pattern of driver genes. HNCDrugResDb is anticipated to have substantial implications for future advancements in drug discovery and optimization of personalized medicine approaches.
- Published
- 2024
- Full Text
- View/download PDF